Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Aug 19, 2026
Why Is Estée Lauder (EL) Stock Up +17.89% Today?

Why Is Estée Lauder (EL) Stock Up +17.89% Today?

Key Takeaways

  • Estée Lauder shares surged roughly 17.89% to about $99.35 in intraday trading, up from a prior close of $84.27.
  • The move was driven by a beat-and-raise fiscal fourth-quarter earnings report that topped Wall Street estimates on both profit and revenue.
  • Management raised its adjusted operating margin guidance, fueling renewed confidence in its turnaround plan.
  • Strong demand in skincare and fragrance, including resilient China sales, underpinned the results.
  • The rally snaps a five-day losing streak and marks a sharp reversal for a stock still down roughly 19% in 2026.

Opening Summary

EL, the ticker for The Estée Lauder Companies Inc., a global leader in prestige beauty across skincare, makeup, fragrance, and hair care, delivered one of its strongest sessions in recent memory. Shares climbed roughly 17.89% to about $99.35, up sharply from the prior session's close of $84.27. The catalyst was a clear one: better-than-expected fiscal fourth-quarter results paired with upbeat forward guidance, which together signaled that the company's multi-year restructuring is finally translating into renewed sales growth and stronger profitability.

Earnings Results and Guidance

The dominant driver of today's rally was the company's fiscal fourth-quarter report. Net sales rose 6.3% to $3.63 billion, exceeding the consensus estimate of roughly $3.55 billion. Adjusted earnings per share came in at $0.39, comfortably above the $0.32 analysts had projected. The quarterly net loss also narrowed dramatically, to about $116 million from $546 million a year earlier, underscoring meaningful progress on the cost side of the business.

Organic net sales grew 5%, marking a fourth consecutive quarter of growth and ending three straight years of annual revenue declines. Perhaps more importantly, management raised its adjusted operating margin outlook to a range of 12.7% to 13.5%, up from a prior preliminary range of 12.5% to 13%. Investors interpreted the combination of accelerating sales and improving margins as evidence that the turnaround, led by CEO Stéphane de La Faverie, is gaining real traction.

Segment Strength and China Demand

Beyond the headline numbers, the results showed broad-based momentum across key product categories. Skincare sales climbed 8.7% to $1.85 billion, while fragrance jumped 10% to $618 million, and makeup rose 2.9%. Only hair care was a soft spot, dipping 0.7%. Notably, the company cited strong demand in China, a market that has weighed on the stock for years, as a contributing factor. That signal of stabilization in a historically challenged region added another layer of optimism to the session's price action.

Restructuring Progress Reinforces the Bull Case

The earnings also validated the company's aggressive "Beauty Reimagined" profit recovery and growth plan. Estée Lauder confirmed a net reduction of roughly 10,000 positions, at the high end of its guided range, and reported about $1.2 billion in gross benefits from the program. While cumulative restructuring charges have been substantial, management framed the effort as a reset that positions the business for sustainable margin expansion and reinvestment in consumer-facing initiatives. The market appeared willing to look past the near-term charges and reward the progress on profitability.

Market Context and Trading Activity

Today's surge represents a sharp reversal of recent momentum. EL entered the session on a five-day losing streak and was down roughly 19% year-to-date, making the rally a notable outlier relative to the broader market's gains. The gap higher on the open suggested heavy buying interest, and the stock pushed above technical levels that had acted as resistance in recent weeks, including its 320-day moving average. The magnitude of the move indicates elevated trading activity and significant short-term repositioning by investors who had been positioned for a more cautious outlook.

What Comes Next for EL

Looking ahead, the focus shifts to whether Estée Lauder can sustain the momentum behind its recovery. The company maintained its fiscal 2027 organic sales growth guidance of 3% to 5%, supported by continued strength in fragrance and skincare and an expected return to growth in makeup. Traders will monitor execution of the restructuring program, the durability of the China rebound, and the company's ability to hold its improved margins against persistent cost pressures and a still-uncertain consumer backdrop. Risks remain, including elevated leverage and the possibility that any stumble in demand could pressure earnings during the transition period.

Trending AI Robots

Tickeron offers hundreds of AI-powered trading bots covering thousands of tickers, but only the strongest performers under current market conditions are featured in its curated Trending AI Robots section. These bots vary by strategy, timeframe, performance metrics, and the symbols they trade, giving traders a way to explore automated approaches tailored to different market environments. Explore the Trending AI Robots page to see which strategies are currently leading.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: EL

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


EL sees MACD Histogram just turned negative

EL saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on September 08, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 48 instances where the indicator turned negative. In 40 of the 48 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 83%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for EL moved out of overbought territory on August 31, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 29 similar instances where the indicator moved out of overbought territory. In 24 of the 29 cases, the stock moved lower in the following days. This puts the odds of a move lower at 83%.

The Momentum Indicator moved below the 0 level on September 24, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on EL as a result. In 67 of 81 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 83%.

EL moved below its 50-day moving average on September 30, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where EL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 76%.

The Aroon Indicator for EL entered a downward trend on October 02, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

Following a +7.34% 3-day Advance, the price is estimated to grow further. Considering data from situations where EL advanced for three days, in 187 of 283 cases, the price rose further within the following month. The odds of a continued upward trend are 66%.

EL may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 40 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 45 (best 1 - 100 worst), indicating steady price growth. EL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 83 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 98 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (9.083) is normal, around the industry mean (17.474). EL's P/E Ratio (191.140) is considerably higher than the industry average of (43.673). Projected Growth (PEG Ratio) (2.121) is also within normal values, averaging (1.518). Dividend Yield (0.015) settles around the average of (0.024) among similar stocks. P/S Ratio (2.317) is also within normal values, averaging (1.884).

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. EL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.

Notable companies

The most notable companies in this group are Procter & Gamble Company (NYSE:PG), Colgate-Palmolive Company (NYSE:CL).

Industry description

Household/Personal Care companies sell products for home cleaning and/or personal hygiene and grooming purposes. Products of this industry include detergents, shampoos, soaps, cosmetics, fabric conditioners and infant care fragrances. Procter & Gamble, Unilever, Estee Lauder and Colgate-Palmolive are some of the biggest names in the business. A lot of the products become a necessary part of people’s daily routine, and therefore the industry is relatively less vulnerable to macroeconomic downturns. At the same time, product quality, consumer safety, and ease of use are extremely critical factors for a company to survive competition and earn recognition in this industry.

Market Cap

The average market capitalization across the Household/Personal Care Industry is 22.7B. The market cap for tickers in the group ranges from 60.48K to 346.15B. PG holds the highest valuation in this group at 346.15B. The lowest valued company is EOSS at 60.48K.

High and low price notable news

The average weekly price growth across all stocks in the Household/Personal Care Industry was -3%. For the same Industry, the average monthly price growth was -6%, and the average quarterly price growth was 7%. ELF experienced the highest price growth at 5%, while BIOT experienced the biggest fall at -18%.

Volume

The average weekly volume growth across all stocks in the Household/Personal Care Industry was 11%. For the same stocks of the Industry, the average monthly volume growth was -17% and the average quarterly volume growth was -30%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 54
P/E Growth Rating: 44
Price Growth Rating: 58
SMR Rating: 73
Profit Risk Rating: 91
Seasonality Score: 15 (-100 ... +100)
View a ticker or compare two or three
EL
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a company which offers skin care, makeup, fragrance and hair care products

Industry HouseholdPersonalCare

Industry
Household Or Personal Care
Address
767 Fifth Avenue
Phone
+1 212 572-4200
Employees
55000
Web
https://www.elcompanies.com
Interact to see
Advertisement
In my view, JPM stands out as the largest U.S. bank by assets and market capitalization, commanding leading market shares across key segments. It holds approximately 11.1% of U.S. retail deposits, 23.6% of credit card sales volume, 8.4% of global investment banking fees, 11.8% of markets revenue, and 10% of treasury services revenue. This diversified "universal banking model" spans consumer and community banking, commercial and investment banking, and asset and wealth management, generating resilient revenue streams.
In recent sessions, WMT has held steady around $124, pulling back from February highs near $134. From what I see, this resilience stands out as the stock has outperformed broader indices year-to-date, thanks to its defensive role in groceries and essentials. Shoppers are leaning toward value options, and consistent volumes show ongoing institutional support. The premium valuation reflects confidence in Walmart's omnichannel progress and market share gains. Even with macro headwinds, I view WMT as a portfolio staple during uncertain times.
I've been following ANTX, a biopharmaceutical company based in Menlo Park, California, that develops novel small molecule therapeutics from its proprietary boron chemistry platform. The focus is on underserved areas like infectious diseases, with the lead candidate epetraborole advancing in Phase 3 trials for non-tuberculous mycobacterial (NTM) lung disease and acute melioidosis. The pipeline also includes AN2-502998 for chronic Chagas disease in preclinical stages, along with programs in oncology.
Tilly's, Inc. (TLYS) operates as a specialty retailer specializing in casual apparel, footwear, accessories, and hardgoods aimed at young men, women, boys, and girls. The company focuses on branded fashion inspired by action sports, surf, and skate culture, offering products like tops, bottoms, swimwear, backpacks, hats, and sunglasses from well-known brands such as Vans and Hurley. With approximately 223 stores in malls and lifestyle centers, complemented by e-commerce through www.tillys.com, Tilly's effectively combines physical and digital sales channels.
NKE shares are tumbling approximately 11% in premarket trading on April 1, 2026, sliding to near nine-year lows after the previous close of $52.82. The primary catalyst is Nike's weak Q4 fiscal 2026 guidance: management projected a 2%–4% revenue decline, sharply missing analyst expectations of approximately 1.9% growth.
Aemetis, Inc. (AMTX) is a renewable natural gas and renewable fuels company focused on developing and commercializing low- and negative-carbon intensity products that replace petroleum-based fuels. The company operates through segments including California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. Its core business model centers on converting agricultural waste—such as dairy manure into biogas and corn/wood waste into ethanol—into high-value biofuels like renewable natural gas (RNG), ethanol, biodiesel, and sustainable aviation fuel precursors.
Silvaco Group, Inc. (SVCO) provides technology computer-aided design (TCAD) software, electronic design automation (EDA) software, and semiconductor intellectual property (SIP) solutions. The company helps semiconductor and photonics firms design, simulate, and optimize processes from atomic-level modeling to complex system-on-chip (SoC) development. Its business centers on licensing software tools and IP blocks, along with engineering services, targeting high-growth areas like AI, power devices, automotive, foundries, and 5G/6G mobile.
UBXG stock surged +79% over the last 30 days, driven by heightened trading volume and positive market sentiment amid broader technology sector trends. Over the past quarter, the stock rose +61%, reflecting recovery from earlier lows near its 52-week bottom.
CVGI stock surged approximately +89% over the last 30 days, driven by strong Q4 2025 earnings beat on revenue and positive 2026 guidance. Over the past quarter, shares rose about +126%, reflecting improved profitability, debt reduction, and a key partnership announcement.
SAFX stock surged +104% over the past 30 days, driven by positive updates on a $10 million capital raise and merger progress. Over the past quarter, the stock rose +44%, reflecting recovery from lows amid renewable energy sector interest and strategic developments.
APTV shares are tumbling approximately 14% in premarket trading on April 1, 2026, representing one of the sharpest single-session losses in the stock's recent history. The primary catalyst is Aptiv's Board of Directors formally approving the long-anticipated spin-off of its Electrical Distribution Systems (EDS) business, now named Versigent, combined with the announcement of a $1.6 billion private offering of senior notes tied to the transaction.
LONA stock surged +80% over the past 30 days, driven by positive analyst upgrades, executive appointments, and full-year financial updates highlighting pipeline progress. Over the past quarter, shares rose +48%, reflecting improved investor sentiment in biotech amid clinical advancements.
Lifetime Brands (LCUT) stock surged +77% over the last 30 days, driven by a strong Q4 earnings beat and a Zacks Rank #1 (Strong Buy) upgrade that reflects an improved earnings outlook. Over the past quarter, shares rose +48%, supported by profitability gains despite softer sales, with adjusted EBITDA reaching $50.8 million for full-year 2025.
RH shares are down approximately 17% in premarket trading on April 1, 2026, after closing the previous session at $139.82, with the stock indicated near $115.76 — a decline of roughly $24 per share. The primary catalyst is a significant Q4 fiscal year 2025 earnings miss, with adjusted EPS of $1.53 coming in well below the Wall Street consensus of $2.22 — a 31% negative surprise.
CURV stock surged approximately +73% over the last 30 days, driven primarily by a positive reaction to Q4 and fiscal 2025 earnings that beat expectations on EPS and revenue. Over the past quarter, the stock is up around +55%, reflecting recovery from lows near $1 amid ongoing store optimization and sub-brand launches
Blaize Holdings, Inc. (BZAI) focuses on artificial intelligence (AI)-enabled edge computing solutions, offering programmable AI processors and platforms for verticals such as smart cities, defense, retail, and enterprise markets. The company's core revolves around hardware like the Graph Streaming Processor (GSP) AI accelerator, compute cards, and software tools including Blaize AI Studio—a no-code/low-code environment for deploying AI models without source code expertise. Based in El Dorado Hills, California, and founded in 2010, it went public through a merger in early 2025.
Comstock Holding Companies, Inc. (CHCI) operates as an asset manager, developer, and operator of mixed-use and transit-oriented properties, mainly in the greater Washington, D.C. metropolitan area. The company targets high-growth urban and suburban markets, overseeing a portfolio that spans residential, commercial, hospitality, and parking assets near key metro stations. Its asset-light, fee-based model delivers recurring revenue through property management, leasing, development services, and asset recapitalization for institutional investors, family offices, and governments.
ORIC Pharmaceuticals shares are down approximately 21% in premarket trading on April 1, 2026, from a prior session close of approximately $12.19, placing the premarket price near $9.63. The primary catalyst is the after-market release of Phase 1b dose optimization data for rinzimetostat (ORIC-944) on March 31, alongside the selection of 400 mg once daily as the recommended Phase 3 dose for the Himalayas-1 registrational trial.
Shares of Target Hospitality Corp. (Nasdaq: TH) surged approximately 38% during Wednesday's trading session, climbing from a prior close of $9.28 to approximately $12.81. The primary catalyst is the company's announcement of a landmark multi-year lease and services agreement worth over $550 million with a top-five global hyperscaler to build and operate a data center workforce community in North Texas.
Shares of Turning Point Brands (TPB) are falling sharply intraday on April 1, 2026, shedding approximately 15% from their prior session close of roughly $87.41, placing the stock near $74.30. The primary catalyst is broad investor risk-off selling tied to mounting trade-policy uncertainty ahead of President Trump's sweeping tariff announcements scheduled for April 2 — a day the administration has branded "Liberation Day".